title: Outcomes of Hodgkin lymphoma patients who relapse after allogeneic stem cell transplantation.
authors.affiliation: Hematology Department, Transplantation Program, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Castagna
authors.affiliation: Hematology Department, Transplantation Program, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy.
authors.forename: B
authors.initials: B
authors.lastname: Sarina
authors.affiliation: Hematology Department, Transplantation Program, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Crocchiolo
authors.affiliation: Hematology Department, Transplantation Program, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Bramanti
authors.affiliation: Hematology Department, Transplantation Program, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Furst
authors.affiliation: Hematology Department, Transplantation Program, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Devillier
authors.affiliation: Hematology Department, Lymphoma Program, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy.
authors.forename: D
authors.initials: D
authors.lastname: Coso
authors.affiliation: Hematology Department, Lymphoma Program, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Bouabdallah
authors.affiliation: Intensive Care Unit, Institut Paoli Calmettes, Marseille, France.
authors.forename: D
authors.initials: D
authors.lastname: Mokart
authors.affiliation: Hematology Department, Transplantation Program, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Morabito
authors.affiliation: Hematology Department, Transplantation Program, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Harbi
authors.affiliation: Biostatistical Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Giordano
authors.affiliation: Hematology Department, Transplantation Program, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Rimondo
authors.affiliation: Hematology Department, Transplantation Program, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Jean Weiller
authors.affiliation: Hematology Department, Transplantation Program, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy.|Department of Medical Biotechnology and Translational Medicine, University of Milano, Milano, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Carlo-Stella
authors.affiliation: Hematology Department, Transplantation Program, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy.|Humanitas University, Rozzano, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Santoro
authors.affiliation: Cell Therapy Unit, Institut Paoli Calmettes, Marseille, France.|Aix-Marseille Université, Marseille, France.|Centre de Recherche en Cancérologie de Marseille, Inserm, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France.
authors.forename: C
authors.initials: C
authors.lastname: Chabannon
authors.affiliation: Hematology Department, Transplantation Program, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy.|Hematology Department, Lymphoma Program, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy.|Aix-Marseille Université, Marseille, France.|Centre de Recherche en Cancérologie de Marseille, Inserm, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France.
authors.forename: D
authors.initials: D
authors.lastname: Blaise
mesh_terms: D000293:Adolescent; D000328:Adult; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D018380:Hematopoietic Stem Cell Transplantation; D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000628:therapy*; D012189:Retrospective Studies; D033581:Stem Cell Transplantation; D013997:Time Factors; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D007166:Immunosuppressive Agents